Virax Biolabs Group Ltd - VRAX

Detailed investor-level table based on 13F positions.

Shareholders (13F)

Quarter: Q1 2026 · Compare: Q4 2025
13D/13G major owners: Ownership tab.
Methodology: Market value and % of portfolio use SEC reported VALUE ($000). For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received. Details.
Rows: 0
Investor History Status Shares held Market value ($000) % of portfolio Previous % Rank Change in shares % change in shares Source Date reported
ARMISTICE CAPITAL, LLC History New 878,803 193 0.0% — 1 +878,803 New Q1 2026 May 15, 2026
Jump Financial, LLC History New 40,724 8 0.0% — 2 +40,724 New Q1 2026 May 14, 2026
XTX Topco Ltd History Closed out 0 0 — 0.0% — -21,437 -100.0% Q1 2026 May 15, 2026
UBS Group AG History Closed out 0 0 — 0.0% — -7,492 -100.0% Q1 2026 May 05, 2026
NATIONAL BANK OF CANADA /FI/ History Closed out 0 0 — 0.0% — -6,000 -100.0% Q1 2026 May 14, 2026
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO History Closed out 0 0 — — — -10 -100.0% Q1 2026 May 07, 2026
OSAIC HOLDINGS, INC. History No change 20 0 — — — 0 0.0% Q1 2026 May 15, 2026
Farther Finance Advisors, LLC History No change 21 0 — — — 0 0.0% Q1 2026 Apr 07, 2026